Log In
Print
BCIQ
Print
Print this Print this
 

Tarceva, erlotinib (R1415, RG115)

Also known as: formerly CP-358,774, OSI-774

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionSmall molecule inhibitor of EGFR tyrosine kinase activity
Molecular Target Epidermal growth factor receptor 1 (EGFR1) (HER1) (ErbB1)
Mechanism of ActionEpidermal growth factor (EGF) receptor 1 (HER1) (ErbB1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today